Serena Martire

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 5

Top Topics

Emergency Medicine

Multiple Sclerosis

Blood Brain Barrier

Transcription Factor

Top Venues

Molecular biology reports

Disease models & mechanisms

Current issues in molecular biology

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Serena Martire, Paola Valentino, Fabiana Marnetto, Luca Mirabile, Marco Capobianco, Antonio Bertolotto
The impact of pre-freezing storage time and temperature on gene expression of blood collected in EDTA tubes. Molecular biology reports 49 (6) (2022)
Francesca Montarolo, Serena Martire, Fabiana Marnetto, Paola Valentino, Sabdi Valverde, Marco Alfonso Capobianco, Antonio Bertolotto
The Selective Agonist for Sphingosine-1-Phosphate Receptors Siponimod Increases the Expression Level of NR4A Genes in Microglia Cell Line. Current issues in molecular biology 44 (3) (2022)
Serena Martire, Francesca Montarolo, Michela Spadaro, Simona Perga, Maria Ludovica Sforza, Luca Marozio, Federica Frezet, Stefania Bruno, Giulia Chiabotto, Maria Chiara Deregibus, Giovanni Camussi, Giovanni Botta, Chiara Benedetto, Antonio Bertolotto
A First Phenotypic and Functional Characterization of Placental Extracellular Vesicles from Women with Multiple Sclerosis. International journal of molecular sciences 22 (6) (2021)
Valeria Valsecchi, Marina Boido, Francesca Montarolo, Michela Guglielmotto, Simona Perga, Serena Martire, Santina Cutrupi, Andrea Iannello, Nadia Gionchiglia, Elena Signorino, Andrea Calvo, Giuseppe Fuda, Adriano Chiò, Antonio Bertolotto, Alessandro Vercelli
The transcription factor Nurr1 is upregulated in amyotrophic lateral sclerosis patients and SOD1-G93A mice. Disease models & mechanisms 13 (5) (2020)
Simona Perga, Francesca Montarolo, Serena Martire, Brigitta Bonaldo, Gabriele Bono, Jessica Bertolo, Roberta Magliozzi, Antonio Bertolotto
Overexpression of the ubiquitin-editing enzyme A20 in the brain lesions of Multiple Sclerosis patients: moving from systemic to central nervous system inflammation. Brain pathology (Zurich, Switzerland) 31 (2) (2020)